2025-10-14 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc. (TDOC) based on the provided information, presented in a structured format with numerical data followed by analysis.

**Report on Teladoc Health Inc. (TDOC)**

Teladoc Health Inc. is a telehealth company that provides virtual healthcare services.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (TDOC):** -60.31%
*   **Cumulative Return (VOO):** 97.72%
*   **Absolute Divergence:** -161.03%
*   **Divergence Range:** Min: -162.5, Max: 312.6
*   **Relative Divergence:** 0.3

**Analysis:** TDOC has significantly underperformed the S&P 500. The large negative divergence indicates substantial relative weakness.  The relative divergence of 0.3 suggests that TDOC's performance is near the lowest end of its historical divergence range compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR     | MDD   | Alpha     | Beta   | Cap(B) |
| :---------- | :------- | :------ | :-------- | :----- | :------- |
| 2015-2017  | 77.0%    | 70.4%   | 51.0%     | -0.1   | 6.2    |
| 2016-2018  | 101.0%   | 69.4%   | 86.0%     | -0.1   | 8.8    |
| 2017-2019  | 141.0%   | 73.8%   | 118.0%    | 0.3    | 14.8   |
| 2018-2020  | 105.0%   | 80.9%   | 81.0%     | 0.3    | 35.3   |
| 2019-2021  | -78.0%   | 80.9%   | -125.0%   | 0.3    | 16.2   |
| 2020-2022  | -252.0%  | 85.9%   | -251.0%   | -0.9   | 4.2    |
| 2021-2023  | -315.0%  | 85.9%   | -316.0%   | -1.8   | 3.8    |
| 2022-2024  | -93.0%   | 85.9%   | -113.0%   | -1.9   | 1.6    |
| 2023-2025  | -31.0%   | 81.6%   | -92.0%    | -0.8   | 1.5    |

**Analysis:**

*   **CAGR:**  The CAGR demonstrates a stark decline over the more recent periods, shifting from substantial growth to significant losses.
*   **MDD:** The Maximum Drawdown remains consistently high, indicating significant risk and volatility.
*   **Alpha:** Alpha is largely negative in recent years, showing underperformance relative to the market risk-free rate.
*   **Beta:** The Beta values shift from slightly negative or positive to more significantly negative, suggesting that TDOC has become less correlated with the market and may even move inversely.
*   **Market Cap:** Market Cap has decreased significantly.

**2. Recent Price Action**

*   **Current Price:** 8.25
*   **Previous Close:** 8.00
*   **Change:** 3.12%
*   **5-day Moving Average:** 8.362
*   **20-day Moving Average:** 8.217
*   **60-day Moving Average:** 7.7832

**Analysis:** The stock price has shown a positive change from the previous close. The price is slightly below the 5-day moving average but above the 20-day and 60-day moving averages, suggesting a potential short-term upward trend but needs confirmation.  The 3.12% change from the previous close indicates a notable short-term price movement.

**3. Market Risk Indicator and Other Indicators**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 48.38
*   **PPO:** -0.29
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (110 shares - Very Safe - MRI:0.90)
*   **Delta_Previous_Relative_Divergence:** -0.5 (Negative: Short-term Decline)
*   **Expected Return (%):** -9592.1%

**Analysis:**

*   The MRI of 0.8 suggests a medium investment recommendation based on risk.
*   The RSI of 48.38 is neutral, indicating neither overbought nor oversold conditions.
*   The PPO of -0.29 indicates that the short-term moving average is slightly below the long-term moving average, suggesting a potential downtrend, but the value is close to zero.
*   The negative change in relative divergence suggests recent underperformance compared to the S&P 500.
*   The Hybrid Signal recommends buying with 100% cash.
*   The extremely negative expected return is concerning and suggests significant long-term underperformance relative to the S&P 500.

**4. Recent News & Significant Events:**

*   **Positive Headlines:** There are headlines suggesting a possible undervaluation ("Assessing Teladoc Health’s Value") and a reason for a stock surge ("Why Is Teladoc (TDOC) Stock Soaring Today").
*   **Negative/Neutral Headlines:** Other headlines point to underperformance compared to peers ("Online Marketplace Stocks Q2 In Review") and mention Teladoc in the context of stocks trading down ("Angi, Chegg, Coinbase, Teladoc, and Fiverr Stocks Trade Down").

**Analysis:**  The news headlines present a mixed picture. While some articles suggest potential value or reasons for short-term price increases, others highlight underperformance and negative market sentiment.

**4-2. Analyst Opinions**

*   **Consensus:** Hold (2.64)
*   **Target Price (avg/high/low):** 9.18 / 12.00 / 7.00
*   **Recent Rating Changes:** Not specified in the provided data.

**Analysis:** The analyst consensus is "Hold," suggesting a neutral outlook. The average target price of $9.18 indicates a potential upside from the current price, but the range is wide, reflecting uncertainty.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출        |
| :--------- | :----- | :---------- |
| 2025-07-30 | -0.19 | 0.63 B$   |
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2025-07-30 | -4.92 | 0.64 B$   |

**Analysis:**

*   **EPS:** EPS has been consistently negative. The high negative EPS values in 2024-08-01 and 2025-07-30 are concerning and may be due to one-time charges or significant losses.
*   **Revenue:** Revenue has been relatively stable around $0.63-0.64 billion.

**6. Financial Information**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-06-30 | $0.63B   | 69.85%       |
| 2025-03-31 | $0.63B   | 68.73%       |
| 2024-12-31 | $0.64B   | 70.50%       |
| 2024-09-30 | $0.64B   | 71.94%       |
| 2024-06-30 | $0.64B   | 70.73%       |

| Quarter    | Equity    | ROE      |
| :--------- | :-------- | :------- |
| 2025-06-30 | $1.42B   | -2.30%   |
| 2025-03-31 | $1.43B   | -6.52%   |
| 2024-12-31 | $1.49B   | -3.25%   |
| 2024-09-30 | $1.51B   | -2.21%   |
| 2024-06-30 | $1.50B   | -55.77% |

**Analysis:**

*   **Revenue:** Revenue is stable, as also seen in the Earnings Analysis.
*   **Profit Margin:** Profit Margins are high, hovering around 70%, which is generally positive.
*   **Equity:** Equity has been decreasing slightly.
*   **ROE:** ROE is negative, indicating that the company is not generating profits from shareholder equity. The large negative ROE in 2024-06-30 aligns with the large EPS loss in the same period.

**7. 종합 Analysis**

Based on the provided data, TDOC presents a mixed picture with significant challenges:

*   **Underperformance:** TDOC has significantly underperformed the S&P 500, with a large negative divergence and negative Alpha.
*   **Financials:** While revenue is stable and profit margins are high, EPS and ROE are negative, indicating a lack of profitability.
*   **Technicals:** The MRI suggests medium risk, and the RSI is neutral. However, the negative Delta_Previous_Relative_Divergence indicates recent underperformance.
*   **News:** News headlines are mixed, with some suggesting potential value but others highlighting ongoing challenges.
*   **Analyst Opinion:** The analyst consensus is "Hold," with a target price offering potential upside, but uncertainty remains.

**Conclusion:**

TDOC faces challenges in profitability and market performance. While revenue and profit margins are strengths, negative EPS, ROE, and significant underperformance compared to the S&P 500 raise concerns. The analyst consensus and target price suggest a potentially neutral to slightly positive outlook, but investors should carefully consider the risks before investing. Given the highly negative expected return, significant caution is advised. The positive price movement today should be viewed in the context of broader challenges.
